These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2875665)

  • 21. Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects.
    Hazra M; Mamo DC; Remington G
    Am J Psychiatry; 2008 Mar; 165(3):396-7; author reply 397-8. PubMed ID: 18316434
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 25. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia.
    Correll CU
    J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
    Schmidt LG; Siemetzki H
    Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapy.
    Brown CS; Wittkowsky AK; Bryant SG
    Pharmacotherapy; 1986; 6(4):193-5. PubMed ID: 2877444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 30. [From neuroleptics toward antipsychotics: practice of changing the treatment, choice of the time and disputes, clinical aspects].
    Plas J
    Encephale; 2003 Sep; 29(Pt 2):S40-2. PubMed ID: 14710536
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient recurrence of auditory hallucinations during acute dystonia.
    Chiu LP
    Br J Psychiatry; 1989 Jul; 155():110-3. PubMed ID: 2575002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.
    Remington GJ; Voineskos G; Pollock B; Reed K; Coulter K
    Am J Psychiatry; 1990 Sep; 147(9):1231-3. PubMed ID: 1974747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alprazolam-neuroleptic combination in schizophrenia.
    Lipinski JF; Cohen BM
    Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amantadine in malignant neuroleptic syndrome].
    Rojtman M; Apter E; Lahav S; Tiano S
    Harefuah; 1981 Apr; 100(7):333. PubMed ID: 6115795
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons from each drug trial.
    Marder SR
    Am J Psychiatry; 2007 Mar; 164(3):375-6. PubMed ID: 17329457
    [No Abstract]   [Full Text] [Related]  

  • 37. Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines.
    Stein M; Dietrich DE; Agelink MW; Becker W; Chrysanthou C; Driessen M; Kruse G; Machleidt W; Reker T; Schneider U; Schulze Mönking H; Emrich HM; Arolt V; Rothermundt M
    Pharmacopsychiatry; 2012 Jul; 45(5):189-95. PubMed ID: 22456956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 39. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome and amantadine withdrawal.
    Lazarus A
    Am J Psychiatry; 1985 Jan; 142(1):142. PubMed ID: 3966578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.